[Combined helium-neon laser therapy in patients with ischemic heart disease].
The paper describes the combined helium-neon-laser (HNL) therapy (intravenous and topical) developed by the authors to treat patients with coronary heart disease. A high efficacy of this therapy mode was demonstrated in patients over 70 years of age with Functional Classes III-IV angina refractory to antianginal agents. The mechanisms responsible for therapeutic efficiency of laser irradiation were studied at the membraneous and cellular levels. There is evidence that the combined HNL-therapy had advantages over topical HNL exposure in terms of higher clinical efficiency and patterns of abnormal chemical changes.
Korochkin
I M
IM
Kartelishev
A V
AV
Babushkina
G V
GV
Kapustina
G M
GM
D000328:Adult; D000368:Aged; D000975:Antioxidants; D001769:Blood / Q000528:radiation effects*; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D004338:Drug Combinations / Q000008:administration & dosage; D005260:Female; D006371:Helium; D006801:Humans; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D009356:Neon; D011879:Radiotherapy Dosage; D014801:Vitamin A / Q000008:administration & dosage*; D014810:Vitamin E / Q000008:administration & dosage*; D014811:Vitamin E Deficiency / Q000150:complications / Q000188:drug therapy
D000975:Antioxidants; D004338:Drug Combinations; D014801:Vitamin A; D014810:Vitamin E; D006371:Helium; D009356:Neon; C048974:vitamin A, vitamin E drug combination
Kombinirovannaia geliĭ-neon-lazernaia terapiia u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.